Curaleaf Granted Final License Approval for Cannabis Dispensary in Ware, Massachusetts

Company to launch its 3rd Adult-Use Dispensary in the State

WAKEFIELD, Mass., Feb. 6, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced it has been granted final license approval by the Massachusetts Cannabis Control Commission to open an adult-use retail dispensary in Ware, Massachusetts.

Curaleaf hopes to schedule post-final inspections soon in an effort to open the adult use location, which will be located at 124 West Street, by early March 2020. The company opened its first adult-use retail location in Oxford, Massachusetts in November 2019 and its second adult-use retail location in Provincetown, Massachusetts on January 29, 2020. The Company also has a medical-only facility in Hanover, Massachusetts.

"Providing high quality and reliable products to patients and customers in our home state of Massachusetts is a big part of our company's strategy," said Curaleaf CEO Joseph Lusardi. "We're excited to be opening our third adult-use dispensary here in the Commonwealth of Massachusetts."

"We will be adding more than twenty new jobs to the local economy and we look forward to building an impactful, positive relationship with the community. We feel very honored to be bringing our business to Ware, located in the Hampshire County and the greater Springfield area," said Curaleaf Massachusetts President Patrik Jonsson.

Curaleaf, headquartered in Massachusetts, is the largest cannabis operator in the U.S. in terms of operational and wholesale footprint, including 53 open dispensaries. Curaleaf currently employs 65 people at its national headquarters in Wakefield, MA and another 150 employees at its local Massachusetts operations.

About Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading vertically integrated multi-state cannabis operator with a dominant presence on both the East and West coasts of the United States, the largest cannabis market in the world. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Strategically positioned in highly populated, limited-license states, the company currently operates in 14 states with 53 dispensaries, 15 cultivation sites 24 processing sites and employs over 2,200 people across the United States. For more information please visit www.curaleaf.com

Visit https://ma.curaleaf.com/  for information on Curaleaf Massachusetts.

INVESTOR CONTACT:
Curaleaf Holdings, Inc.
Dan Foley, VP, Finance and Investor Relations
IR@curaleaf.com 

MEDIA CONTACTS:
Tracy Brady, VP Corporate Communications, Curaleaf
tbrady@curaleaf.com 

Casey Sherman, Regan Communications
csherman@regancomm.com

FORWARD LOOKING STATEMENTS

This media advisory contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", " expects" or, "proposed", "is expected", "intends", "anticipates", " or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward‐looking statements and information concerning the opening of a Massachusetts dispensary and the status of other Massachusetts operations. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed September 23, 2019, which is available under the Company's SEDAR profile at www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release.  The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cision View original content:http://www.prnewswire.com/news-releases/curaleaf-granted-final-license-approval-for-cannabis-dispensary-in-ware-massachusetts-301000493.html

SOURCE Curaleaf Holdings, Inc.